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Multi-slice-computed tomography coronary angiography (CTA) provides direct non-invasive
anatomic assessment of the coronary arteries allowing for early identiﬁcation of coronary
artery disease (CAD). This information is useful for diagnosis of CAD, particularly the rule out
of CAD. In addition, early identiﬁcation of CAD with CTA may also be useful for risk strati-
ﬁcation. The purpose of this review is to provide an overview of the current literature on the
prognostic value of CTA and to discuss how the prognostic information obtained with CTA can
be used to further integrate the technique into clinical practice. Non-invasive anatomic
assessment of plaque burden, location, composition, and remodeling using CTA may provide
prognostically relevant information. This information has been shown to be incremental to the
Framingham risk score, coronary artery calcium scoring, and myocardial perfusion imaging.
Characterization of atherosclerosis non-invasively has the potential to provide important
prognostic information enabling a more patient-tailored approach to disease management.
Future studies assessing outcome after CTA-based risk adjustments are needed to further
understand the value of detailed non-invasive anatomic imaging.
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INTRODUCTION
The introduction of multi-slice-computed tomogra-
phy coronary angiography (CTA) has changed the ﬁeld
of non-invasive imaging. In addition to existing func-
tional imaging techniques assessing myocardial per-
fusion and wall motion, CTA currently provides direct
non-invasive anatomic assessment of the coronary
arteries. This allows for detection of coronary artery
disease (CAD) at an earlier stage compared to functional
imaging,
1 which may have important implications for
the diagnosis as well as prognosis of CAD. For diag-
nosis, numerous studies support the use of CTA for rule
out of the presence of CAD with a high accuracy.
2-8 As a
result the technique is increasingly used as a gatekeeper
for further diagnostic testing. In addition, data are
emerging that early identiﬁcation of CAD with CTA
may be useful for risk stratiﬁcation. Since the ﬁrst
publications on the prognostic value of CTA in 2007 a
number of studies have been published providing further
insight into the potential value of non-invasive anatomic
imaging for risk stratiﬁcation.
8-21 The purpose of this
review is to provide an overview of the literature on the
prognostic value of CTA and to discuss how the prog-
nostic information obtained with CTA can be used to
further integrate the technique into clinical practice.
ACCURACY FOR RISK STRATIFICATION
Shift From Stenosis To Atherosclerosis
Diagnostic accuracy studies assessing the value
of CTA have determined its ability to identify the
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970presence or absence of signiﬁcant stenosis (C50%
luminal narrowing).
3,22-26 This threshold is important
from a diagnostic point of view, as it can identify a
cause for the patient’s complaints as well as a treatment
target for revascularization. Furthermore, patients with
a signiﬁcant stenosis on CTA may have worse out-
come as compared to patients without signiﬁcant
CAD.
14,15,18,20 Indeed, an annualized event rate for
the occurrence of all cause mortality and myocardial
infarction ranging between approximately 1% and
5%
14,15,18,20 has been observed in patients with sig-
niﬁcant CAD compared to approximately 0-2% in
patients without signiﬁcant CAD. However CTA can
further differentiate patients as having non-signiﬁcant
CAD or completely normal coronary arteries. This is
important as the presence of non-signiﬁcant CAD may
not necessarily be considered benign.
27-29 Indeed,
myocardial infarction and unstable angina are fre-
quently caused by lesions deemed to be non-signiﬁcant
prior to the event.
30-33 In line with this notion, the
presence of non-signiﬁcant CAD on CTA has been
associated with an increased annualized event rates up
to 1.5%,
14,18,20 compared to a very low annualized
event rates of \0.7% in patients with completely nor-
mal coronary anatomy.
8-10,12-14,18,20,34 Accordingly,
classiﬁcation of patients as having normal anatomy,
non-signiﬁcant CAD, or signiﬁcant CAD may allow
straightforward and reliable risk stratiﬁcation. How-
ever, it is conceivable that the prognostic information
may be reﬁned by further characterization of the
observed atherosclerosis on segmental or plaque level.
Potentially, such analysis may include identiﬁcation of
certain characteristics of lesions that may have a higher
likelihood to cause thrombotic occlusion of the vessel
and subsequent coronary events.
In the past, numerous histological studies have
addressed the mechanism underlying coronary occlusion,
thereby identifying three major causes, namely plaque
erosion, the presence of calciﬁed nodules and, in the
majority of cases, plaque rupture.
35 In the setting of
plaque rupture, the underlying plaque at the site of
thrombus formation has been typically characterized as a
lesion with a large lipid-rich atheromatous necrotic core,
with a ruptured thin ﬁbrous cap and expansive remod-
eling. These ﬁndings have subsequently led to the
hypothesis that plaque rupture is caused by rupture of the
thin ﬁbrous cap overlying a lesion with a large lipid-rich
atheromatous necrotic core (Figure 1). In addition to
morphological characteristics of the plaque, the presence
of inﬂammation, as reﬂected by macrophages and lym-
phocytes inﬁltration, also plays an important role. An
overview of morphological plaque characteristics asso-
ciated with vulnerability is provided in Table 1.
36 Due to
its ability to visualize the vessel wall, CTA may allow
non-invasive identiﬁcation of several characteristics
associated with vulnerability including plaque burden,
location, composition, and remodeling.
37-48
Figure 1. Thin capped ﬁbroatheroma as a cause of plaque
rupture. The top panel shows a histological specimen of a
ruptured plaque. As can be observed in the specimen, the
lumen is completely occluded by a large thrombus. The
underlying plaque contains a large necrotic core (nc) and is
covered by a thin ﬁbrous cap (fc) which has ruptured (pr).
These ﬁndings have subsequently led to the hypothesis that
plaque rupture is caused by rupture of the thin ﬁbrous cap of
thin capped ﬁbroatheroma plaques. A histological specimen of
a thin capped ﬁbroatheroma can be observed in the bottom
panel. The plaque is characterized by a large necrotic
atheromatous core (similar to the necrotic core observed in
sites of plaque rupture), covered by a thin non-ruptured ﬁbrous
cap. Adapted and reprinted with permission from Jain et al.
78
Table 1. Morphological markers of plaque vulner-
ability
Plaque
Plaque cap thickness
Plaque lipid core size
Plaque stenosis
Color
Collagen content versus lipid content, mechanical
stability
Calciﬁcation burden and pattern
Pan arterial
Total coronary calcium burden
Total arterial burden of plaque including peripheral
Based on the table from Naghavi et al.
36
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Plaque burden and location. By combining
plaque extent and severity throughout the coronary
system, plaque burden can be either assessed quantita-
tively or semi-quantitatively with CTA by summation of
the number of diseased and signiﬁcantly diseased ves-
sels or segments. Although plaque burden in itself does
not directly imply plaque vulnerability, an increase in
plaque burden is associated with an increased risk for
vulnerable plaques. Several studies have attempted to
create models of plaque burden using a modiﬁed AHA
segment model of the coronary artery tree. In the study
by Pundziute et al,
8 increased number of segments with
plaque as well as increased number of segments with
signiﬁcant stenosis were independent predictors of
events when corrected for baseline clinical variables.
Using similar scoring methods, other studies have also
observed a higher risk for events in patients with
increased number of segments with atherosclerosis.
10,16
Min et al observed that a segmental involvement score
allowed good differentiation between patients with a low
and high risk for future events. In patients with more
than ﬁve segments involved, an absolute event rate of
8.4% was observed compared to 2.5% in patients with a
score B5.
16 In a next step, the extent and severity of
atherosclerosis throughout the coronary artery tree was
incorporated into the segmental severity score. Each
coronary segment was graded according to stenosis
severity (absent to severe plaque (0-3)) and the scores
for all segments were combined. When using this
segmental severity score an absolute event rate of 6.6%
was observed in patients with a score [5 compared to
1.6% in patients with a score B5.
In addition to plaque burden, plaque location should
be considered as well, as vulnerable plaques are most
often observed in proximal segments of the coronary
artery tree.
49 The presence of proximal lesions is
therefore associated with an increased risk of vulnerable
plaques. Furthermore, plaque rupture in a proximal
segment also increases the risk of a major cardiac event,
due to the larger volume of myocardium that is at risk.
Indeed, Pundziute et al
8 observed that the presence of
left main plaque or proximal LAD plaque was an
important independent predictor of events associated
with a high event rate. Likewise, in the study by Min
et al
16 the presence of any left main stenosis was also an
independent predictor of events. Subsequently, the
authors created a modiﬁed version of the Duke coronary
artery score by combining both plaque burden and
location into a single predictive model. As illustrated in
Figure 2, events rates paralleled increasing disease
severity as determined with this hierarchic model.
Plaque remodeling and plaque composi-
tion. To some extent, CTA allows assessment of
plaque composition. A differentiation can be made
between non-calciﬁed plaques having low attenuation,
calciﬁed plaques with high attenuation, and mixed pla-
ques with both non-calciﬁed and calciﬁed elements
(Figure 3).
47 Furthermore, plaque remodeling, a marker
of vulnerability, can also be appreciated (Figure 4). In
retrospective studies comparing observations on CTA
Figure 2. Prognostic value of CTA. Cumulative survival curves illustrating the risk of events in
each category of the Duke Prognostic Coronary Artery Disease Index. The risk of events increases
with increasingly higher disease severity categories. Reprinted with permission from Min et al.
16
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patients with suspected acute coronary syndrome (ACS),
more outward plaque remodeling, non-calciﬁed plaque,
and mixed plaque were observed in the latter.
41,50,51 In
subsequent prognostic investigations these characteris-
tics have been further studied. Pundziute et al
8 assessed
the prognostic value of different plaque characteristics
and observed that increased number of segments with
mixed plaques was an independent predictor of events.
Non-calciﬁed plaque however has also been associated
with an increased risk for events. Both the number of
segments with mixed plaques as well as the number of
segments with non-calciﬁed plaque were independent
predictors of events in a recent study by Van Werkhoven
et al.
20 Furthermore, the presence of substantial non-
calciﬁed plaque burden was demonstrated to provide
incremental prognostic value over the presence of sig-
niﬁcant stenosis on CTA. In a recent study by
Motoyama et al
17 the concept of plaque morphology was
investigated more extensively in 1059 patients during an
average follow up of 27 months. The authors assessed
the presence of two plaque characteristics, low attenu-
ation plaque and positive remodeling, and recorded the
occurrence of ACS during follow-up. In patients with a
normal CTA study no events occurred. In patients with
atherosclerosis but without either high-risk plaque fea-
ture (e.g., absence of both low-attenuation plaque tissue
and positive remodeling) the event rate was 0.49%
whereas in patients with plaques positive for 1 high-risk
feature (either low attenuation or positive remodeling)
the event rate increased to 3.7%. Finally, the majority of
events occurred in patients with both high-risk plaque
features. In these patients an event rate as high as 22.2%
was observed (Figure 5). Accordingly, these ﬁndings
may provide a proof of concept for the assessment of
plaque composition on CTA for risk stratiﬁcation.
INTEGRATION INTO CLINICAL PRACTICE
Relation to Existing Tools for Risk
Stratiﬁcation
As outlined above, several investigations have
demonstrated the feasibility of CTA for risk stratiﬁca-
tion. An important question however remains whether
the technique provides incremental prognostic informa-
tion to existing risk stratiﬁcation methods. To a large
extent, prognosis is determined using baseline clinical
Figure 3. Plaque composition assessed with CTA. Curved multi-planar reconstructions showing
three distinct plaque characteristics observed on CTA with non-calciﬁed plaque (arrow, left panel),
mixed plaque (arrow, mid-panel), and calciﬁed plaque (arrow, right panel). CTA, Multi-slice
computed tomography coronary angiography.
Figure 4. Example of a positively remodeled plaque. A multi-
planar reconstruction of the left anterior descending coronary
artery. In the proximal section of the vessel a large plaque can
be observed between the lumen (purple line) and the vessel
wall (yellow line). The diameter of the vessel at the plaque site
is clearly larger compared to the diameter at the reference
section (r), indicating positive remodeling (p). Adapted and
reprinted with permission from Motoyama et al.
17 LAD, Left
anterior descending artery.
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widely used and provides an estimate of the risk of
developing adverse coronary events.
52 The disadvantage
of this method is that it is a population-based screening
tool, whereas CTA may provide a more patient-speciﬁc
approach. In a recent investigation by Hadamitzky
et al
15 the value of risk stratiﬁcation with CTA was
compared to the Framingham risk score in a population
of 1256 patients during an average follow-up of
18 months. Figure 6 illustrates the difference between
the predicted risk based on the Framingham risk score
and the observed risk according to ﬁndings on CTA. In
patients without obstructive CAD on CTA, the observed
risk was signiﬁcantly lower than predicted by the Fra-
mingham risk score. In contrast signiﬁcantly more
events were observed in patients with obstructive CAD
compared to the predicted event rate. CTA may there-
fore further reﬁne risk stratiﬁcation over conventional
risk assessment alone.
Of note, the incremental value of atherosclerosis
over traditional risk assessment has been shown in the
past for coronary artery calcium scoring (Figure 7).
53-56
Based on numerous trials, coronary artery calcium
scoring—performed either by electron beam computed
tomography or CT—has been accepted as a robust tool
for prognostiﬁcation, especially in asymptomatic indi-
viduals.
57 In addition, the technique may be used in
symptomatic patients to identify the presence and the
extent of atherosclerosis.
58 However, the technique can
only provide an estimate of total calciﬁed plaque burden,
and does not provide any information on the stenosis
severity nor the presence and extent of non-calciﬁed
plaque burden. An important advantage of CTA there-
fore is the additional information on stenosis severity
and plaque composition. In a study by Ostrom et al
18 the
incremental value of non-invasive coronary angiography
with electron-beam-computed tomography over coro-
nary calcium was assessed. The authors demonstrated
that CTA-derived plaque burden, deﬁned as the number
of non-signiﬁcantly or signiﬁcantly diseased vessels, had
independent and incremental value in predicting all-
cause mortality independent of age, gender, conven-
tional risk factors, and coronary artery calcium score.
Similar ﬁndings were recently reported by Rubinshtein
et al.
19 In a more recent study the incremental prognostic
value of both stenosis severity and plaque composition
on CTA over the coronary artery calcium score was
determined.
21 In addition to stenosis severity the number
of segments with non-calciﬁed plaque as well as the
number of segments with mixed plaque was shown to be
independently associated with increased risk for events.
Accordingly, it appears that non-invasive measures of
plaque extent, severity, and composition not only pro-
vide improved diagnostic information but also incre-
mental prognostic information over coronary artery
calcium scoring.
Although risk stratiﬁcation using non-invasive
anatomic imaging is gaining momentum, traditionally
functional imaging has been used extensively for this
purpose. Particularly myocardial perfusion imaging is an
established and important technique for prognosis.
Patients with a normal perfusion have a very low event
rate compared to increased event rates in patients with
abnormal perfusion
59-65 Comparative studies between
CTA and myocardial perfusion imaging have shown that
CTA provides complementary information to myocar-
dial perfusion imaging when regarding the diagnosis of
Figure 5. Prognostic value of low-attenuation plaque and
plaque remodeling features. Survival curves illustrating the
prognostic value of 2 plaque features (low-attenuation plaque
and remodeling) associated with acute coronary syndrome.
The event rate increased in patients with 1 feature positive
plaques and was highest in patients with both high risk
features. Reprinted with permission from Motoyama et al.
17
Figure 6. Prognostic value of CTA in addition to the
Framingham risk score. In patients without obstructive CAD,
the observed risk was signiﬁcantly lower than predicted by the
Framingham risk score. In contrast signiﬁcantly more events
were observed in patients with obstructive CAD compared to
the predicted event rate. Reprinted with permission from
Hadamitzky et al.
15 CAD, Coronary artery disease.
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66-69 The added value of this complementary
information for risk stratiﬁcation was recently deter-
mined.
20 Several CTA variables were able to provide
prognostic information independent of myocardial per-
fusion imaging. On a patient level the presence of
signiﬁcant CAD (C50% stenosis) was identiﬁed as a
robust independent predictor. In addition to stenosis
severity, plaque composition was shown to further
enhance risk stratiﬁcation, as illustrated in Figure 8.
Patient Populations
Symptomatic populations. CTA has been
proposed for diagnosis of signiﬁcant CAD in symp-
tomatic patients presenting with an intermediate pre-test
likelihood for signiﬁcant stenosis. Based on the diag-
nostic accuracy of CTA for the detection of signiﬁcant
CAD on conventional coronary angiography, the com-
parative studies between CTA and myocardial perfusion
imaging, and the limited prognostic data at the time, an
algorithm has been proposed which integrates the use of
these techniques for the diagnosis and management of
this patient population (Figure 9).
70 The algorithm sep-
arates patients into three strategies for management:
ﬁrst, patients with normal coronary anatomy can be
safely discharged, secondly patients with non-ﬂow lim-
iting atherosclerosis requiring medical treatment and
aggressive risk factor modiﬁcation and ﬁnally patients
with a ﬂow-limiting stenosis requiring further evaluation
with conventional coronary angiography with potential
revascularization. The currently available outcome data
support that the discharge of patients with a normal CTA
study is safe as low events rates have been conﬁrmed in
these patients.
8-10,12-14,18,20,34 However in patients with
atherosclerosis regardless of stenosis severity, assess-
ment of plaque extent, composition, location, and
remodeling may further improve risk stratiﬁcation. As
indicated by initial data, this information can be valu-
able both in patients with or without ischemia.
20
CTA is currently not recommended for diagnosis in
other populations than those with an intermediate pre-
test likelihood for signiﬁcant CAD. It is however con-
ceivable that in the future CTA may be used in other
populations with the purpose of risk stratiﬁcation. In
symptomatic patients with a low pre-test likelihood for
signiﬁcant stenosis, non-invasive imaging is generally
not indicated for diagnosis. However assessment of
atherosclerosis can be useful in identifying patients at
increased risk of future events. As shown by Henneman
et al, the prevalence of atherosclerosis in patients with a
low pre-test likelihood is approximately 40% which
illustrates that, although the pre-test likelihood for sig-
niﬁcant stenosis is low, atherosclerosis is nevertheless
present in a large proportion of these patients. In patients
Figure 7. Prognostic value of coronary calcium scoring. Cumulative survival curves illustrating
the event rate in increasingly higher calcium score categories. Reprinted with permission from
Budoff et al.
54
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functional data may be more relevant than CTA to
determine need for revascularization. However, CTA
can potentially be used as a second line test for risk
stratiﬁcation as the anatomic information has been
shown to provide incremental prognostic information to
myocardial perfusion imaging alone.
20
Asymptomatic populations. Although only
limited data are available in asymptomatic patient pop-
ulations it is possible that CTA is valuable for risk
stratiﬁcation in these patients. On the one hand, CTA
can be used to identify patients with severe CAD, such
as triple vessel disease or left main disease, and who
may beneﬁt from aggressive intervention. On the other
hand, CTA can be performed to document atheroscle-
rosis for long-term risk assessment. In a recent study in
1000 asymptomatic individuals undergoing CTA the
prevalence of atherosclerosis was reported to be 22%.
11
During a follow-up of 17 months, coronary events
(unstable angina and revascularization) occurred in 15
(1.5%) individuals, all of which had atherosclerosis on
CTA. However, the majority of events were revascu-
larizations, triggered by the CTA results. In combination
with the low overall event rate, these observations
indicate the limited value of screening for atheroscle-
rosis with CTA in this population. Accordingly, CTA is
currently not acceptable as a general screening tool and
CS testing or truly non-invasive approaches may be
preferable. However, as proposed by Naghavi et al
36
non-invasive coronary angiography may potentially be
used as a downstream test in the workup of asymp-
tomatic individuals with high-risk characteristics,
following home- or ofﬁce-based screening (Figure 10).
Through selection of high-risk patients with truly non-
invasive techniques only a small subgroup of high-risk
patients remains in which further non-invasive and
subsequent invasive imaging may be beneﬁcial. Future
studies will need to determine the value and feasibility
of such a screening strategy.
LIMITATIONS
Although the available data support the potential
clinical relevance of assessment of plaque characteris-
tics on CTA, accurate quantiﬁcation of plaque remains
challenging, while requiring optimal image quality.
Leber et al
44 have reported on the accuracy of 64-slice
CTA to classify and quantify plaque volumes in the
proximal coronary arteries as compared to intravascular
ultrasound. CTA, detected calciﬁed and mixed plaque
with high accuracy (95 and 94%, respectively) but
accuracy was lower for non-calciﬁed lesions (83%).
When regarding plaque volume, non-calciﬁed plaque
and mixed plaque volumes were systematically under-
estimated whereas calciﬁed plaque volume was over-
estimated by CTA. Novel software packages aimed at
Figure 8. Incremental prognostic value of CTA over MPI. Bar graph illustrating the incremental
prognostic value (depicted by Chi-square value on the y axis) of CTA. The addition of CTA
provides incremental prognostic information to baseline clinical variables and MPI. Furthermore,
the addition of non-calciﬁed plaque on CTA results in further incremental prognostic information
over baseline clinical variables, MPI, and signiﬁcant CAD (C50% stenosis) on CTA. Reprinted
with permission from Van Werkhoven et al.
20 CAD, Coronary artery disease; CTA, multi-slice
computed tomography coronary angiography; MPI, myocardial perfusion imaging.
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currently being developed and may improve not only
accuracy but also reproducibility of measurements.
In addition, the radiation dose remains a cause of
concern for CTA. Currently traditional 64-slice CTA
protocols are still associated with high radiation expo-
sure, although the radiation dose of CTA has recently
decreased substantially.
71-74 Importantly, low-dose CTA
with prospective ECG triggering has recently been
shown to reduce radiation burden while maintaining
image quality and a high diagnostic accuracy.
75,76 Cur-
rently, the radiation burden with these novel acquisition
techniques is approaching the level of diagnostic cath-
eterization or even lower.
77
CONCLUSION
Non-invasive anatomic assessment of plaque bur-
den, location, composition, and remodeling using CTA
may provide prognostically relevant information, incre-
mental to not only the Framingham risk score, but also
to other imaging approaches as coronary artery calcium
scoring and myocardial perfusion imaging. Thus, non-
invasive characterization of atherosclerosis has the
potential to provide a more patient-tailored approach to
disease management. Future studies assessing outcome
after CTA-based risk adjustments are needed to further
understand the value of detailed non-invasive anatomic
imaging.
Figure 9. Algorithm illustrating the sequential use of CTA and functional imaging in patients with
an intermediate pre-test likelihood. Reprinted with permission from Schuijf et al.
70 CTA, Multi-
slice computed tomography coronary angiography.
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